Security key
881624209
TEVA PHARMACEUTICAL INDUSTRIES LTD - Ordinary Shares, par value NIS 0.01 per share (TEVA)
CUSIP: 881624209
Q1 2020 13F Holders as of 31 Mar 2020
- Security type / class
- Equity / Ordinary Shares, par value NIS 0.01 per share
- Total 13F shares
- 553,974,646
- Total 13F value
- $4,971,872,721
- Share change
- -46,593,417
- Put/Call ratio
- 164%
- SEC-reported price per share
- $8.98
- Number of holders
- 430
- Value change
- -$440,161,645
- Number of buys
- 218
- Number of sells
- 165
- Shares outstanding
- 1,148,777,709
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q1 2020
Institutions
430
Top holders
10
TEVA full security history
Ownership snapshot
Full 13F holder table
TEVA PHARMACEUTICAL INDUSTRIES LTD SEC filings
TEVA PHARMACEUTICAL INDUSTRIES LTD company facts
Broader feeds
Ownership snapshot
Top reported holders of TEVA - TEVA PHARMACEUTICAL INDUSTRIES LTD - Ordinary Shares, par value NIS 0.01 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Capital Research Global I...
Disclosed value leader
Capital Research Global I...
Comparable rows
15/15
Latest evidence
31 Dec 2019
13F
Lead comparable stake: 11%
Showing 1-6 of 15 holder rows.
Quick read
Capital Research Global Investors leads the comparable SEC ownership view at 11%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Capital Research Global Investors's linked filing trail.
Comparable ownership
Top 5
Capital Research Global Investors
11%
WELLINGTON MANAGEMENT GROUP LLP
6.8%
BERKSHIRE HATHAWAY INC
3.8%
BlackRock Finance, Inc.
3.1%
Capital World Investors
3.1%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Capital Research Global Investors |
13F
Company
|
11%
|
$1,283,315,000
130,950,677 shares
|
— | 31 Dec 2019 |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
Company
|
6.8%
|
$761,427,000
77,696,748 shares
|
— | 31 Dec 2019 |
| BERKSHIRE HATHAWAY INC |
13F
Company
|
3.8%
|
$423,843,000
43,249,295 shares
|
— | 31 Dec 2019 |
| BlackRock Finance, Inc. |
13F
Company
|
3.1%
|
$353,432,000
36,064,323 shares
|
— | 31 Dec 2019 |
| Capital World Investors |
13F
Company
|
3.1%
|
$349,987,000
35,713,062 shares
|
— | 31 Dec 2019 |
| ABRAMS CAPITAL MANAGEMENT, L.P. |
13F
Company
|
2.1%
|
$235,654,000
24,046,356 shares
|
— | 31 Dec 2019 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q1 2020
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
430
Shares
553,974,646
Rows available
430
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q1 2020 vs Q1 2020 Across Filers
Q1 2020 holders
430
Q1 2020 holders
430
Holder diff
0
| Investor | Q1 2020 Shares | Q1 2020 Shares | Share Diff | Share Chg % | Q1 2020 value | Q1 2020 value | Value change | Value Chg % |
|---|